Introduction
The death domain (DD) and death effector domain (DED) are two of the four domains that form a structural superfamily of proteinprotein interaction modules referred to as the death motif (1) (2) (3) . These domains were first identified in proteins that mediate programmed cell death, but are now recognized to act as protein-interaction domains in a variety of cellular signaling pathways (4) .
The three-dimensional structures of the DD and DED are very similar to one another, sharing a common overall fold composed of six helices with a greek key topology (5) . Protein-protein interactions involving these motifs have been thought to be exclusively homotypic among apoptotic effectors (6) (7) (8) (9) (10) (11) (12) (13) ), yet no mechanism by which these domains recognize one another among cell death proteins has been described. There is only one three-dimensional structure of a pair of interacting DDs that could provide clues into the protein-protein interaction mechanism by this domain fold. The X-ray crystal structure of Drosophila Tube DD bound to the DD of Pelle kinase (10) illustrates that helices 2 and 6 of Tube engage helices 3 and 4 of Pelle within the DD of each protein. Additional interactions occur between an irregularly structured Cterminal tail of Tube and helices 4 and 5 of Pelle. Elements of the Tube/Pelle complex have been observed for the interaction between the apoptosis-related receptor CD95 (Fas, Apo-1) and the death adaptor FADD (Mort-1) (14, 15) . Yeast two-hybrid and biochemical analyses of the DED of FADD (16, 17) and the DED of the phosphoprotein enriched in astrocytes PEA-15 (13, 18) extended the Tube/Pelle-like interaction scheme to the DED. Analysis of the proteinprotein interactions between DD-and/or DED-containing proteins and their binding partners suggests that proteins harboring the DD and/or DED may pair with one another in a Tube/Pelle-like fashion.
Biochemical characterization of the death adaptors FADD and the TNFR1-associated death domain protein TRADD (19) and dissection of how these adaptors recognize their binding partners suggests that these adaptors have a preferential binding surface for each other and for their cognate receptors. Reconstitution of wild type and mutant complexes between FADD, TRADD and their binding partners in vitro, under overexpression conditions in cell culture and in adaptor-deficient cells (20) has revealed that FADD uses a Tube-like interaction surface for binding either receptor CD95 (14) or adaptor TRADD. TRADD operates in a complementary fashion, using its Pelle-like surface to engage FADD or TNFR1. These observations demonstrate that there is an intrinsic specificity for protein partnerships built into the domain fold of a given adaptor. By defining the topology of these relationships, we propose that death adaptors utilize their Tube-and Pelle-like binding surfaces to discriminate one receptor from another to form distinct molecular complexes in cell death signal transduction.
Material and Methods
Expression constructs and mutagenesis FADD and FADD-HA were prepared are previously described (14) . For generation of stable cell lines, various FADD constructs/mutants were cloned in the pcDNA3.1Puro (16, 17) . TRADD DD (residues 195-312) was prepared as a GSTfusion protein and full-length TRADD cloned into the pcDNA 3.0 (Invitrogen). TNFR1 fulllength (residues 2-455) was cloned in the pCMV-HA vector (BD Biosciences Clontech) with an N-terminal HA tag. TNFR1 IC (residues 243-455) was cloned into pET21a (Invitrogen). Site directed mutagenesis of FADD, TRADD and TNFR1 was carried out using the QuickChange Kit from Stratagene.
Proteins
GST-TRADD DD mutants were expressed in BL21 E.coli (Novagen) and purified on Glutathione-Agarose beads (Amersham Pharmacia) according to the manufactuerer's directions.
35 S-Met labelled proteins were expressed by coupled transcription/translation (Promega) according to the manufacturer's directions. Full-length FADD was expressed from pET28b and TNFR1 was expressed from pET21a. The structural integrity of the FADD mutants was verified by NMR spectroscopy as previously described (14) .
Reconstitution of receptor/adaptor complexes 10-20 μl beads of a 50% slurry of each GST-TRADD mutant (similar protein amount), 10 μ l of the 35 S-labelled FADD or TNFR1-IC were mixed in 150 μl binding buffer (50 mM Hepes, pH 7.4, 50 mM NaCl, 0.1% NP-40, 5 mM EDTA, 10 % Glycerol) and nutated for 2 hours at 4°C. The beads were harvested by centrifugation and the beads washed 3 times with 500 μl of binding buffer for 5 minutes at 4°C. Associated proteins were eluted with SDS-PAGE loading dye at 95°C and visualized by SDS-Tris/Tricine PAGE and phosphorimaging of the dried gel. Apoptosis assay 1X10 6 Jurkat cells/ml were treated with varying amounts of FasL (Apotech) or 100 ng/ml TNF (Apotech) and 1μg/ml cycloheximide for 3 hours at 37°C. Cells were stained with the FITC conjugated Annexin V (FITC-Annexin V) and propidium iodide (PI) (Sigma-Aldrich). 3X10 4 cells were acquired on a FACSCalibur flow cytometer (Becton Dickinson) and analysed using the CellQuest software (BD Biosciences). Apoptotic cells were quantified as the percentage of cells stained with Annexin V.
Cell culture, transient transfection

Co-immunoprecipitation
For the IP of TRADD mutants with FADD in cell culture, 30 μl of a 50 % slurry anti-cMyc Agarose conjugate (Sigma) was mixed with 500 μg cell extract in a 500 μl volume and incubated with nutation for 4 hours at 4°C. The beads were recovered, washed 4 times with 500 μl of lysis buffer and resuspended in 25 μl of SDS-PAGE loading dye and boiled for 5 minutes at 95°C. 10 μl of each co-IP fraction was separated by SDS-Tris/Tricine PAGE and blotted on nitrocellulose membranes. The nitrocellulose membranes were blocked with casein blocker (Pierce), followed by incubation of the membrane for 1-2 hours at room temperature with an anti-HA antibody (3F10, Roche). The reaction was developed with a chemiluminescent substrate (Pierce).
IP of TNFR1 mutants with TRADD was achieved by co-transfection and activation with 2 μ g Flag-TNF ( Apotech). 750 μl supernatant was precipitated with 30 μl of M2 affinity beads (Sigma) for 4 hours at 4°C (21) . The beads were washed 4 times with 750 μl of lysis buffer and resuspended in 30 μl of SDS-sample buffer. The beads were boiled for 5 minutes at 95°C and 10 μl of each sample was analysed by SDS-PAGE and western blotting. IP of TNFR1 with TRADD mutants was achieved by the same procedure.
Homology modelling A homology model of TRADD was built using the program MODELLER (22) . The initial sequence alignment began with a structure-based alignment of FADD and TNFR1 using DALI (23) . The amino-acid sequence of TRADD DD was then aligned with FADD and TNFR1 to decide on the initial placement of TRADD sequence according to the known secondary structure elements in FADD and TNFR1 and the sequence similarity with TRADD. Iterative realignment was done using the quality score (Z-score) reported from a surface potential energy analysis using Prosa 3.0 (24). The final Z-score of the model was -5.34. PROCHECK was used to check the stereochemical quality of the model (25) .
Results
Identification of a pairing mechanism for death adaptors
The TNFR1-associated death domain protein TRADD contains an N-terminal TRAFinteraction motif and a C-terminal DD. The TRADD DD is responsible for both interaction with the intracellular domain of TNFR1 and the DD of the Fas-associated death domain protein FADD. To identify the FADD binding surface of TRADD, twentyeight site-specific mutations were introduced into the TRADD DD and screened by a GST-TRADD DD pull down assay against fulllength FADD (Figs. 1, 2 and Table 1 ). Five TRADD mutants (D246R, E255R, F266E, Q267A and R278A) were found to be unable to associate with FADD in this assay (Fig. 1A , Table 1 ). A subset of these binding-defective mutations were subsequently introduced into the full-length protein and tested for their ability to co-immunoprecipitate (co-IP) with FADD following ectopic expression of TRADD and FADD in HEK 293 cells. Three of the TRADD mutants that failed to associate with FADD in the pull down assay (E255R, Q267A and R278A) also failed to co-IP with FADD from cell lysates (Fig. 1B) . Q274E, a mutant that was modestly defective in the pull down assay, failed to associate with FADD inside cells. These four mutations cluster on one face of the TRADD DD (Fig. 1C) .
Using a similar approach, twenty-one mutants in FADD, which included surface exposed residues in both the DD and DED, were screened by pull down with GST-TRADD DD (Table 2) . Four mutants, exclusively in the DD (R113E, R117E, D123E and D175R), disrupted the interaction between GST-TRADD DD and FADD ( Fig. 2A) . R113E and D175R were stably transfected into Jurkat I2.1 FADD-deficient cells and found to be defective in both FasL-and TNF -induced cell death by flow cytometry with FITC-Annnexin V (Fig. 2B ). These positions in FADD reside on the opposite side of the DD-fold relative to binding-deficient mutants of TRADD (Fig. 2C) .
We previously described a pairing mechanism for homotypic interactions between FADD and CD95 (Fas, Apo-1) (14) in which we related the distribution of CD95-binding residues in FADD DD to Drosophila Tube DD (10) .
In this scheme, we topologically relate the surface of the DD in FADD to the surface of the DD of Tube and refer to FADD DD as Tube-like in its approach to CD95. According to this scheme, the TRADD-binding residues of FADD reside on the Tube-like surface of the FADD DD. Moreover, these TRADD-binding residues are a subset of the FADD residues implicated in binding CD95, suggesting that FADD uses a common surface to bind a death receptor or another adaptor (see also 26) .
TRADD, on the other hand, displays its binding information on the opposite surface of its DD relative to FADD. This surface we refer to as having a Pelle-like topology, again in reference to the X-ray crystal structure of the Tube/Pelle DD complex (10) . Thus, a Tube/Pelle-like pairing mechanism can illustrate how death adaptors interact with one another.
An intrinsic preference for a Tube-or Pellelike approach to a binding partner
The Tube/Pelle-like pairing mechanism between FADD and TRADD was further explored for TRADD's interaction with TNFR1.
Of the twenty-eight mutants introduced into the TRADD DD (Table 1) , ten mutants disrupted the interaction with TNFR1 IC in a GST-TRADD DD pull down assay (Fig. 3A) . Four of these defective mutants were introduced into full-length TRADD and tested for their ability to co-IP with TNFR1 when transiently co-expressed with TNFR1 in HEK 293 cells (Fig. 3B) . Mutants in TRADD that disrupted the interaction with TNFR1 overlap with the positions in TRADD that are responsible for FADD binding. Thus, TRADD uses the same surface to engage either FADD or TNFR1.
Taken
Thus, fourteen TNFR1 mutants were generated and assessed by a pull down assay for their ability to bind to GST-TRADD DD (Table 3) . Four mutants (R341E, R347A, G403E, E406R) were deficient in TRADD DD binding (Fig. 4A) . These residues are located on the Tube-like surface of the TNFR1 DD, confirming the prediction. Further analysis of these TNFR1 mutants was carried out by co-expression with TRADD and immunoprecipitated with Flag-TNF . R347A and E406R failed to co-IP with TRADD (Fig.  4B) , confirming the pull down results (Fig.  4A) . Another mutant, D353A, although only modestly defective in the pull down assay (Fig. 4A) , fails to co-IP with TRADD ( Fig.  4B ) in agreement with previous results (27) . However, one mutation that had previously been reported to be defective for TRADD binding, E369A, may have disrupted the local fold of the domain (27) . E369K (Table 3 ), a more drastic change which includes the introduction of an oppositely charged and more bulky residue, has no effect on the interaction with TRADD in a pull down assay (Table 3 ) and co-IPs with TRADD from HEK 293 cells (not shown), in contrast to E369A (27) . Despite these differences, it is apparent that the bulk of the TRADD binding determinants on TNFR1 reside on the Tubelike surface.
Discussion
The identification of the binding determinants between death adaptors and their binding partners define a Tube/Pelle-like pairing scheme for the components of a deathinducing signaling complex. At least for the interactions tested, Tube-like or Pelle-like preferences are evident for a given death adaptor, whether or not the binding partner of an adaptor is its cognate receptor or another adaptor. Adaptor TRADD, for example, uses its Pelle-like surface to bind receptor TNFR1 or a second adaptor, FADD. The preference for TRADD's binding determinants to reside on the Pelle-like surface of its DD, whether it recognizes a receptor or another adaptor, suggests that death adaptors can discriminate their cognate partners from all others. Our observations that TRADD's binding surface for FADD and TNFR1 overlap agree with the composition of the protein complexes in which TRADD is biologically active in cell death (1, 28) . FADD and TRADD interact with one another via their DDs in forming a soluble complex with TRAF2 and RIP1 in response to an apoptotic stimulus at TNFR1 (28). TRADD's Pelle-like binding surface for TNFR1 or FADD overlap, indicating that FADD and TNFR1 have incompatible binding surfaces to engage one another, consistent with their roles in distinct molecular complexes containing TRADD (27) (28) (29) . The Pelle-like preference for TRADD's interaction with its binding partners, therefore, defines a scheme by which TRADD can distinguish its binding targets from other proteins harboring similar motifs. FADD, too, organizes its binding determinants along a preferred surface, which we designate as Tube-like. This surface resides on the opposite side of a death domain relative to the Pelle-like surface.
The Tube-like or Pelle-like preferences we have observed for the death adaptors FADD and TRADD are striking in view of the sequence similarity between FADD, TRADD and TNFR1 (Fig. 5) .
Pairwise sequence similarity for the Tube-like DDs of FADD and TNFR1 is 35% and their three-dimensional structures are quite similar to one another, with a best fit superposition of 3.3Å over 69 C positions (9, 11, 12) . Although the majority of these similarities involve residues that form the hydrophobic core of the death domain fold, the residues we have identified as part of the protein-protein interaction surface are also conserved between FADD and TNFR1 (solid circles, Fig. 5A ). The Pelle-like binder TRADD, on the other hand, is similar in amino-acid sequence to FADD (33% similar) and TNFR1 (31% similar), but conserved residues that reside on the Tubelike binding surface in TRADD can be mutated with no effect on function (open circles, Fig. 5A ). Similarly, the residues of TRADD implicated in FADD and/or TNFR1 binding (closed squares, Fig. 5A ), are often conserved in the Tube-like binders, but their mutation in FADD or TNFR1 fails to disrupt function (open squares, Fig. 5A ). Thus, there is a clear polarity to the presentation of binding determinants on the DD-fold for Tube-like and Pelle-like classes of death domains. The origin of the Tube-or Pelle-like preference, therefore, has to be rooted in a key difference in the three-dimensional structure of Tube-like and Pelle-like binding domains. In the absence of a three-dimensional structure of TRADD, we can only speculate on the structural difference from the amino-acid sequences of TRADD, FADD and TNFR1 and the homology model of TRADD. From the amino-acid sequence, the Tube-like surface of TRADD is more negatively charged relative to FADD and TNFR1. This is readily seen from an electrostatic surface representation of the TRADD homology model (Fig. 5B) , wherein a dense patch of negative charge dominates the Tube-like surface (red shading, Fig. 5B ). These acidic residues reside in the C-terminal half of -helix 5 and in the loop between helices 5 and 6. There is also a significantly longer loop between helices 2 and 3 (Y256-G260), which includes several additional acidic residues that could contribute to the surface charge on the molecule. Although still requiring confirmation with the actual three-dimensional structure of the TRADD DD, these observations suggest that TRADD's preference for use of its Pelle-like surface may be rooted in the distribution of charged residues on the surface. This is reminiscent of the mechanism of proteinprotein interaction observed between the CARD domains of Apaf-1 and procaspase-9, where a very negatively charged surface on Apaf-1 engages a complementary positively charged surface in procaspase-9 (30). Although there is an extensive hydrogenbonding network at the Apaf-1/procaspase-9 interface, polarities of charge are a hallmark of the CARD-CARD interface (30) . If charge polarity is also a component of TRADD's interaction with FADD or TNFR1, then the distribution of charge might reflect distinct surfaces of a DD that could be used by an adaptor to discriminate its cognate partners from other similar proteins. FADD and TNFR1 can be viewed from a similar perspective, where patches of positive and negative surface charge are apparent on the Tube-like faces on each of these DDs (Fig.  5B) . Thus, the three-dimensional structures of FADD and TNFR1 along with modeling of TRADD suggest an intrinsic organization to these domains that define how they will interact with their cognate binding partners. This is not to say that an individual death domain cannot use its Tube-like and Pelle-like surfaces simultaneously to bind different factors in the same multi-protein complex. Rather, the distribution of surface charge would define which binding partner engages the Tube-like face and which binding partner engages the Pelle-like face. For each of the molecules assessed in this study, there are known binding partners whose surface of interaction with FADD or TRADD may now be predictable on the basis of our observations. We believe, therefore, we have uncovered a mechanism by which a death adaptor can discriminate its binding partners and direct the assembly of a higher-order signaling complex. (Fig. 2C) . (Tables 1 and 2 ). TRADD is manually aligned by amino-acid sequence to the structure-based alignment of FADD and TNFR1. Pair-wise similar or identical residues between TRADD and FADD or TNFR1 are shown in red. Closed squares represent positions in TRADD whose mutation disrupted proteinprotein interaction with FADD and/or TNFR1. Open circles represent positions on the Tube-like surface of TRADD whose mutation had no effect on protein-protein interaction. Open squares represent positions in FADD (above) or TNFR1 (below) whose mutation had no effect on protein-protein interaction with TRADD (see Tables 1 and 2 ). B) Electrostatic surface representation of the FADD (pdb accession code 1E3Y (11)), TNFR1 (pdb accession code 1ICH (12) ) and the TRADD homology model calculated with the program PYMOL (32) . Positive charge is shown in blue, negative charge in red. Residues that form part of the Tube-like protein-interaction surface of these domains are labeled for FADD and TNFR1. The position of E299 is shown in TRADD to highlight a Tube-like residue of TRADD whose mutation has no effect on its interaction with TNFR1 or FADD.
